Key result
Study investigates endomyocardial biopsy pathology and echo indices in NICM but reports no results.
Why the study?
The usefulness of obtaining an endomyocardial biopsy from the RV and LV, and its associations with echocardiographic parameters, had not been explored.
What is the relationship between pathological evaluation of endomyocardial biopsy from the right and left ventricles and echocardiographic indices in patients with non-ischemic cardiomyopathy?
What is the relationship between pathological evaluation of endomyocardial biopsy from the right and left ventricles and echocardiographic indices in patients with non-ischemic cardiomyopathy?
This study aims to explore the previously uninvestigated associations between biventricular endomyocardial biopsy findings and echocardiographic parameters in non-ischemic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
No reported biopsy-echocardiographic correlations in non-ischemic cardiomyopathy; leaves open their diagnostic or prognostic value.
Background: Endomyocardial biopsy (EMB) is a useful modality in diagnosing the origin of cardiomyopathy and the condition of the impaired myocardium. However, the usefulness of obtaining an EMB from the right and left ventricles (RV and LV, respectively), and its associations with echocardiographic parameters, have not been explored.
No takes yet. Share an insight, caveat, or question.
Toyosaki et al. (2023) studied this question. Pathological evaluation of endomyocardial biopsy was investigated for its relationship with echocardiographic indices in non-ischemic cardiomyopathy, but the abstract provides no results.
Synapse has enriched 10 related papers. Consider them for comparative context: